Yamada M - Search Results

1

Myricetin prevents high molecular weight Aβ_1-42 oligomer-induced neurotoxicity through antioxidant effects in cell membranes and mitochondria.

Kimura AM, Tsuji M, Yasumoto T, Mori Y, Oguchi T, Tsuji Y, Umino M, Umino A, Nishikawa T, Nakamura S, Inoue T, Kiuchi Y, Yamada M, Teplow DB, Ono K. Kimura AM, et al. Among authors: yamada m. Free Radic Biol Med. 2021 Aug 1;171:232-244. doi: 10.1016/j.freeradbiomed.2021.05.019. Epub 2021 May 17. Free Radic Biol Med. 2021. PMID: 34015458

2

Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro.

Ono K, Yamada M. Ono K, et al. Among authors: yamada m. J Neurochem. 2006 Apr;97(1):105-15. doi: 10.1111/j.1471-4159.2006.03707.x. Epub 2006 Mar 8. J Neurochem. 2006. PMID: 16524383 Free article.

3

Anti-amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimer's disease.

Ono K, Hamaguchi T, Naiki H, Yamada M. Ono K, et al. Among authors: yamada m. Biochim Biophys Acta. 2006 Jun;1762(6):575-86. doi: 10.1016/j.bbadis.2006.03.002. Epub 2006 Apr 7. Biochim Biophys Acta. 2006. PMID: 16644188 Free article. Review.

4

The development of preventives and therapeutics for Alzheimer's disease that inhibit the formation of beta-amyloid fibrils (fAbeta), as well as destabilize preformed fAbeta.

Ono K, Naiki H, Yamada M. Ono K, et al. Among authors: yamada m. Curr Pharm Des. 2006;12(33):4357-75. doi: 10.2174/138161206778793010. Curr Pharm Des. 2006. PMID: 17105432 Review.

5

REVIEW: Curcumin and Alzheimer's disease.

Hamaguchi T, Ono K, Yamada M. Hamaguchi T, et al. Among authors: yamada m. CNS Neurosci Ther. 2010 Oct;16(5):285-97. doi: 10.1111/j.1755-5949.2010.00147.x. CNS Neurosci Ther. 2010. PMID: 20406252 Free PMC article. Review.

6

Cerebrospinal Fluid from Alzheimer's disease patients promotes amyloid beta-protein oligomerization.

Ikeda T, Ono K, Elashoff D, Condron MM, Noguchi-Shinohara M, Yoshita M, Teplow DB, Yamada M. Ikeda T, et al. Among authors: yamada m. J Alzheimers Dis. 2010;21(1):81-6. doi: 10.3233/JAD-2010-100075. J Alzheimers Dis. 2010. PMID: 20413863

7

Low-n oligomers as therapeutic targets of Alzheimer's disease.

Ono K, Yamada M. Ono K, et al. Among authors: yamada m. J Neurochem. 2011 Apr;117(1):19-28. doi: 10.1111/j.1471-4159.2011.07187.x. Epub 2011 Feb 9. J Neurochem. 2011. PMID: 21244429 Free article. Review.

8

Vitamin A and Alzheimer's disease.

Ono K, Yamada M. Ono K, et al. Among authors: yamada m. Geriatr Gerontol Int. 2012 Apr;12(2):180-8. doi: 10.1111/j.1447-0594.2011.00786.x. Epub 2011 Dec 23. Geriatr Gerontol Int. 2012. PMID: 22221326 Review.

9

Phenolic compounds prevent amyloid β-protein oligomerization and synaptic dysfunction by site-specific binding.

Ono K, Li L, Takamura Y, Yoshiike Y, Zhu L, Han F, Mao X, Ikeda T, Takasaki J, Nishijo H, Takashima A, Teplow DB, Zagorski MG, Yamada M. Ono K, et al. Among authors: yamada m. J Biol Chem. 2012 Apr 27;287(18):14631-43. doi: 10.1074/jbc.M111.325456. Epub 2012 Mar 5. J Biol Chem. 2012. PMID: 22393064 Free PMC article.

10

Cross-seeding effects of amyloid β-protein and α-synuclein.

Ono K, Takahashi R, Ikeda T, Yamada M. Ono K, et al. Among authors: yamada m. J Neurochem. 2012 Sep;122(5):883-90. doi: 10.1111/j.1471-4159.2012.07847.x. Epub 2012 Jul 23. J Neurochem. 2012. PMID: 22734715 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,703 results

Search Page